Literature DB >> 17225870

Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes.

Emese Tóth-Zsámboki1, Eszter Horváth, Katarina Vargova, Eszter Pankotai, Kanneganti Murthy, Zsuzsanna Zsengellér, Tamás Bárány, Tamás Pék, Katalin Fekete, Róbert Gábor Kiss, István Préda, Zsombor Lacza, Domokos Gerö, Csaba Szabó.   

Abstract

Reactive free radical and oxidant production leads to DNA damage during myocardial ischemia/reperfusion. Consequent overactivation of poly(ADP-ribose) polymerase (PARP) promotes cellular energy deficit and necrosis. We hypothesized that PARP is activated in circulating leukocytes in patients with myocardial infarction and reperfusion during primary percutaneous coronary intervention (PCI). In 15 patients with ST segment elevation acute myocardial infarction, before and after primary PCI and 24 and 96 h later, we determined serum hydrogen peroxide concentrations, plasma levels of the oxidative DNA adduct 8-hydroxy-2'-deoxyguanosine (8OHdG), tyrosine nitration, PARP activation, and translocation of apoptosis-inducing factor (AIF) in circulating leukocytes. Plasma 8OHdG levels and leukocyte tyrosine nitration were rapidly increased by PCI. Similarly, poly(ADP-ribose) content of the leukocytes increased in cells isolated just after PCI, indicating immediate PARP activation triggered by reperfusion of the myocardium. In contrast, serum hydrogen peroxide concentrations and the translocation of AIF gradually increased over time and were most pronounced at 96 h. Reperfusion-related oxidative/nitrosative stress triggers DNA damage, which leads to PARP activation in circulating leukocytes. Translocation of AIF and lipid peroxidation occurs at a later stage. These results represent the first direct demonstration of PARP activation in human myocardial infarction. Future work is required to test whether pharmacological inhibition of PARP may offer myocardial protection during primary PCI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17225870      PMCID: PMC1770007          DOI: 10.2119/2006–00055.Toth-Zsamboki

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  32 in total

1.  Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury.

Authors:  Z Yang; B Zingarelli; C Szabó
Journal:  Shock       Date:  2000-01       Impact factor: 3.454

2.  Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?

Authors:  K Martijn Akkerhuis; John H Alexander; Barbara E Tardiff; Eric Boersma; Robert A Harrington; A Michael Lincoff; Maarten L Simoons
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

Review 3.  Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.

Authors:  László Virág; Eva Szabó; Pál Gergely; Csaba Szabó
Journal:  Toxicol Lett       Date:  2003-04-11       Impact factor: 4.372

4.  Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.

Authors:  L Liaudet; L Timashpolsky; L Virág; A Cziráki; C Szabó
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 5.  Clinical perspectives of PARP inhibitors.

Authors:  Grazia Graziani; Csaba Szabó
Journal:  Pharmacol Res       Date:  2005-07       Impact factor: 7.658

Review 6.  Cellular mechanisms of ischemia-reperfusion injury.

Authors:  H Michael Piper; Karsten Meuter; Claudia Schäfer
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

Review 7.  The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

Authors:  László Virág; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

8.  Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.

Authors:  Tanveer A Khan; Marc Ruel; Cesario Bianchi; Pierre Voisine; Katalin Komjáti; Csaba Szabo; Frank W Sellke
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

9.  Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells.

Authors:  Ana Carrillo; Yolanda Monreal; Pablo Ramírez; Luis Marin; Pascual Parrilla; Francisco Javier Oliver; José Yélamos
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

10.  Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.

Authors:  Kanneganti G K Murthy; Chun-Yang Xiao; Jon G Mabley; Min Chen; Csaba Szabó
Journal:  Shock       Date:  2004-03       Impact factor: 3.454

View more
  23 in total

Review 1.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

2.  Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.

Authors:  Domokos Gerö; Petra Szoleczky; Athanasia Chatzianastasiou; Andreas Papapetropoulos; Csaba Szabo
Journal:  Mol Med       Date:  2014-07-31       Impact factor: 6.354

3.  The Angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury.

Authors:  Sven Asmussen; Eva Bartha; Gabor Olah; Elena Sbrana; Sebastian W Rehberg; Yusuke Yamamoto; Perenlei Enkhbaatar; Hal K Hawkins; Hiroshi Ito; Robert A Cox; Lillian D Traber; Daniel L Traber; Csaba Szabo
Journal:  Shock       Date:  2011-10       Impact factor: 3.454

Review 4.  Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling.

Authors:  Zsolt Radak; Zhongfu Zhao; Erika Koltai; Hideki Ohno; Mustafa Atalay
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

5.  Increased poly(ADP-ribosyl)ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment.

Authors:  Gábor Oláh; Celeste C Finnerty; Elena Sbrana; Itoro Elijah; Domokos Gerö; David N Herndon; Csaba Szabó
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

6.  Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Authors:  Katalin Módis; Domokos Gero; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

7.  Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury.

Authors:  Perenlei Enkhbaatar; Rhykka Connelly; Jianpu Wang; Yoshimitsu Nakano; Matthias Lange; Atsumori Hamahata; Eszter Horvath; Csaba Szabo; Stefan Jaroch; Peter Hölscher; Margrit Hillmann; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Daniel L Traber
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

8.  Upregulation and Mitochondrial Sequestration of Hemoglobin Occur in Circulating Leukocytes during Critical Illness, Conferring a Cytoprotective Phenotype.

Authors:  Attila Brunyanszki; Katalin Erdelyi; Bartosz Szczesny; Gabor Olah; Reinaldo Salomao; David N Herndon; Csaba Szabo
Journal:  Mol Med       Date:  2015-08-17       Impact factor: 6.354

Review 9.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 10.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.